March 13, 2017
TiGenix’s hearth attack study confirms the long term safety
TiGenix has found in its acute hearth attack study that allogenic cardiac stem cells can be transplanted safely through the coronary tree.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: AlloCSC